VR Logo

Maravai LifeSciences Holdings Inc. Class A (MRVI) download report


Healthcare | Biotechnology & Pharma Research

Maravai LifeSciences Holdings Inc. Class A (MRVI) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally.

IPO Date: 20-Nov-2020

Co-Founder, Chairman & CEO: Mr. Carl W. Hull

Exec. VP & CFO: Mr. Kevin M. Herde

Listing: NASDAQ: MRVI

Country: United States

Headquarters: San Diego, CA

Website: https://www.maravai.com

Key Facts

Market cap: $7,163.66 Mln

Revenue (TTM): $895.32 Mln

Earnings (TTM): $226.04 Mln

Cash: $431.47 Mln

Total Debt: $529.94 Mln

Insider's Holding: 0.16%

Liquidity: Low

52 Week range: $23.16 - 63.55

Shares outstanding: 131,538,000

Stock Performance

Time Period Maravai LifeSciences Holdings Inc. Class A (MRVI) S&P BSE Sensex S&P Midcap 400
YTD-34.65-8.97-19.36
1 month-20.13-3.38-9.77
3 months-23.24-7.93-15.66
1 Year-35.300.55-15.12
3 Years--10.415.61
5 Years--11.455.47
10 Years--12.059.61
As on 29-Jun-2022
Year Maravai LifeSciences Holdings Inc. Class A (MRVI) S&P Midcap 400 S&P BSE Sensex
202149.3823.2121.99